The Moderna pharmaceutical corporation logo is pictured in a file image. (Photo by Nicolas Economou/NurPhoto via Getty Images) WASHINGTON - The Food and Drug Administration said its preliminary analysis confirmed the effectiveness and safety of Moderna’s COVID-19 vaccine, a key step toward approval of a second coronavirus vaccine in the U.S.A panel of outside experts will offer their recommendation Thursday, with a final FDA decision expected soon thereafter.The FDA’s briefing document released Tuesday revealed no safety objections from the agency and deemed the vaccine to have a “favorable safety profile.”"Safety data from a November 11, 2020 interim analysis of approximately 30,350 participants ...